Project Details
Description
Diabetic macular edema degeneration occur is a vision threatening condition. The investigators compare the efficacy of BEOVU and Eylea intravitreal treatment in the management.
Layman's description
Baseline ,and postoperative 1 ,6 and 12 months full ophthalmic examination was done. Procedure included randomized intravitreal injection of Brolucizumab(BEOVU®, Genentech, South Francisco, CA) and of aflibercept (Eylea;Regeneron, Tarrytown,NY).
| Status | Finished |
|---|---|
| Effective start/end date | 12/01/21 → 30/04/22 |
Collaborative partners
- Benha University (lead)
- Ibn Nafees Medical Center
- Abu Dhabi Health Services Company
Keywords
- BEOVU
- Eylea
- Diabetic Macular Edema
- Retinal Degeneration
- Macular Degeneration
- Retinal Diseases
- Eye Diseases
- Macular Edema
- Edema
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.